87 related articles for article (PubMed ID: 33012976)
1. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and
Yang S; Park SJ; Oh T; Cho H; Chae C
Can J Vet Res; 2020 Oct; 84(4):272-282. PubMed ID: 33012976
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
[TBL] [Abstract][Full Text] [Related]
3. A field efficacy trial of a trivalent vaccine containing porcine circovirus type 2a and 2b, and Mycoplasma hyopneumoniae in three herds.
Um H; Yang S; Oh T; Cho H; Park KH; Suh J; Chae C
Vet Med Sci; 2022 Mar; 8(2):578-590. PubMed ID: 34687172
[TBL] [Abstract][Full Text] [Related]
4. Cross-protection of a porcine circovirus types 2a/b (PCV-2a/b) and
Suh J; Ham S; Oh T; Chae C
Can J Vet Res; 2023 Oct; 87(4):297-302. PubMed ID: 37790269
[TBL] [Abstract][Full Text] [Related]
5. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
[TBL] [Abstract][Full Text] [Related]
6. Field evaluation of novel plant-derived porcine circovirus type 2 vaccine related to subclinical infection.
Park KH; Cho H; Suh J; Oh T; Park Y; Park S; Sohn EJ; Chae C
Vet Med Sci; 2023 Nov; 9(6):2703-2710. PubMed ID: 37665771
[TBL] [Abstract][Full Text] [Related]
7. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
[TBL] [Abstract][Full Text] [Related]
8. Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge.
Seo HW; Park C; Han K; Chae C
Vet Res; 2014 Feb; 45(1):13. PubMed ID: 24484292
[TBL] [Abstract][Full Text] [Related]
9. Divergent clinical outcomes depending on the sequential infection order of porcine circovirus type 2 and Mycoplasma hyopneumoniae.
Suh J; Ham S; Chae C
Vet Microbiol; 2024 May; 292():110060. PubMed ID: 38520754
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the protective efficacy of virus-like particles based on PCV 2b and 2d subtypes against mixed challenge in mice.
Yuan XM; Yuan QC; Feng SM; Deng ZB
Pol J Vet Sci; 2022 Jun; 25(2):195-205. PubMed ID: 35861994
[TBL] [Abstract][Full Text] [Related]
11. A new strategy to develop pseudorabies virus-based bivalent vaccine with high immunogenicity of porcine circovirus type 2.
Wu X; Wu H; Wang H; Luo L; Wang J; Wu B; He Q; Cao G; Lei Y; Chen X; Dai J
Vet Microbiol; 2021 Apr; 255():109022. PubMed ID: 33711567
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of porcine circovirus type 2 nucleic acid vaccine containing CpG motif for mice.
Li J; Yu J; Xu S; Shi J; Xu S; Wu X; Fu F; Peng Z; Zhang L; Zheng S; Yuan X; Cong X; Sun W; Cheng K; Du Y; Wu J; Wang J
Virol J; 2016 Nov; 13(1):185. PubMed ID: 27842600
[TBL] [Abstract][Full Text] [Related]
13. A porcine circovirus type 2d-based virus-like particle vaccine induces humoral and cellular immune responses and effectively protects pigs against PCV2d challenge.
Kim K; Choi K; Shin M; Hahn TW
Front Microbiol; 2023; 14():1334968. PubMed ID: 38274769
[TBL] [Abstract][Full Text] [Related]
14. Design of a New Vaccine Prototype against Porcine Circovirus Type 2 (PCV2),
Arrieta-Mendoza D; Garces B; Hidalgo AA; Neira V; Ramirez G; Neira-Carrillo A; Bucarey SA
Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793801
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antimicrobial consumption in weaning pigs in Danish sow herds with different vaccine purchase patterns during 2013.
Temtem C; Kruse AB; Nielsen LR; Pedersen KS; Alban L
Porcine Health Manag; 2016; 2():23. PubMed ID: 28405449
[TBL] [Abstract][Full Text] [Related]
16. Live-Attenuated
Lloren KKS; Lee JH
Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140182
[TBL] [Abstract][Full Text] [Related]
17. Chimeric proteins of Mycoplasma hyopneumoniae as vaccine and preclinical model for immunological evaluation.
Santos MR; Toledo LT; Bassi ÊJ; Porto WJN; Bressan GC; Moreira MAS; Chang YF; Silva-Júnior A
Braz J Microbiol; 2024 Mar; 55(1):943-953. PubMed ID: 38217795
[TBL] [Abstract][Full Text] [Related]
18. High levels of maternally derived antibodies do not significantly interfere with the development of humoral and cell-mediated responses to Porcine circovirus 2 after intradermal vaccination.
Martin-Valls GE; Cortey M; Swam H; Jiménez M; Mateu E
Porcine Health Manag; 2023 Sep; 9(1):40. PubMed ID: 37715214
[TBL] [Abstract][Full Text] [Related]
19. Comparative immunogenic and immunoprotective activities of PCV2d Cap and Rep antigens delivered by an efficient eukaryotic expression system engineered into a Salmonella vaccine vector.
Lloren KKS; Sivasankar C; Lee JH
Vet Microbiol; 2024 Jun; 295():110151. PubMed ID: 38870752
[TBL] [Abstract][Full Text] [Related]
20. Effect of Live and Fragmented
Vega-Munguía G; Vargas Sánchez A; Camacho-Medina JE; Suárez-Vélez L; Bárcenas-Morales G; Quintar Guerrero D; Ciprian-Carrasco A; Mendoza Elvira S
Pathogens; 2024 Apr; 13(4):. PubMed ID: 38668277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
